封面
市场调查报告书
商品编码
1611184

全球 DNA 微阵列市场规模、份额和趋势分析报告:按类型、应用、最终用途、地区和细分市场进行预测(2025-2030 年)

DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

DNA 微阵列市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计2030年全球DNA微阵列市场规模将达35.3亿美元,2025年至2030年复合年增长率为8.8%。

由于技术进步和主要参与企业增加的研发投资,DNA 微阵列市场预计将出现显着的成长机会。此外,DNA微阵列技术在遗传疾病诊断、癌症研究和个人化医疗等各种应用中的日益采用是推动全球市场的关键因素。

快速、准确的疾病诊断对于适当的患者治疗至关重要。分子相互作用和检测技术的最新进展透过提供新的​​诊断解决方案正在升级临床诊断服务。同样,诊断 DNA 微阵列的最新进展也为市场相关人员开闢了新的途径。 DNA微阵列技术应用于基因型鉴定、疾病诊断、异常检测和核苷酸多态性筛检。

此外,由于研究经费的增加、医疗保健成本的上升、技术的进步以及对精确和客製化治疗解决方案的需求不断增加,预计全球 DNA 微阵列市场将出现指数级成长机会。例如,据 Med City INVEST Precision Medicine 称,消费者对某些治疗方法)的认识正在增强。

此外,领先公司增加对製造有效和先进诊断工具的投资以及市场参与企业的各种策略倡议可能会创造新的扩张途径。例如,2022年9月,Illumina, Inc.宣布推出其下一代科技产品NovaSeq X-Series,每年可产生超过20,000个基因组。此外,2021 年 9 月,Schott MiniFab 收购了一家位于亚利桑那州的微阵列解决方案公司。此次收购预计将增强我们在美国的生物科学能力。

DNA 微阵列市场报告亮点

  • 寡核苷酸 DNA 微阵列因其成本效益和监测基因组中所有基因表现的能力而占据最大的市场份额。
  • 互补 DNA 微阵列片段由于其广泛的应用,如多态性筛检、基因组 DNA 克隆作图和基因发现,预计将记录最快的成长率。
  • 由于基因表现在临床诊断、药物发现、微生物学和其他最终用途等各种应用中的采用,到 2024 年,基因表现分析领域将占据最大的市场。
  • 按最终用途划分,学术和研究机构细分市场预计将在 2024 年占据市场主导地位,而诊断中心细分市场预计在预测期内增长最快。
  • 由于基因组研究资金的激增和基因检测意识的增强,预计亚太地区将在预测期内出现最快的增长。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 DNA 微阵列市场变数、趋势与范围

  • 市场体系展望
    • 母市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 渗透率和成长前景图
  • DNA 微阵列:市场分析工具
    • 产业分析:波特五力分析
    • PESTLE分析
  • 法律规范

第四章 DNA 微阵列市场細項分析:按类型(2018-2030)

  • 定义和范围
  • 类型市场占有率分析(2022/2030)
  • 细分仪表板
  • 全球 DNA 微阵列市场:按类型(2018-2030)
  • 市场规模、预测与趋势分析(2018-2030)
    • 互补DNA微阵列
    • 寡核苷酸 DNA 微阵列

第五章 DNA 微阵列市场細項分析:依应用分类(2018-2030)

  • 定义和范围
  • 应用市场占有率分析(2022/2030)
  • 细分仪表板
  • 全球 DNA 微阵列市场:依应用分类(2018-2030)
  • 市场规模、预测与趋势分析(2018-2030)
    • 基因表现分析
    • 基因型鉴定
    • 其他的

第六章 DNA 微阵列市场細項分析:依最终用途分类(2018-2030)

  • 定义和范围
  • 最终用途市场占有率分析(2022/2030)
  • 细分仪表板
  • 全球 DNA 微阵列市场:依最终用途分类(2018-2030)
  • 市场规模、预测与趋势分析(2018-2030)
    • 製药和生物技术公司
    • 诊断中心
    • 医院和诊所
    • 学术/研究机构
    • 其他的

第七章 DNA 微阵列市场細項分析:按地区(2018-2030)

  • 定义和范围
  • 区域市场占有率分析(2022/2030)
  • 区域市场仪表板
  • 区域市场简介
  • SWOT分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 市场规模、预测、收益、趋势分析(2022-2030)
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲

第八章 DNA 微阵列市场:竞争分析

  • 主要市场参与企业的最新趋势和影响分析
    • 安索夫成长矩阵
    • 热图分析
    • 主要交易及策略联盟分析
  • 公司分类
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
  • 上市公司
    • 竞争仪表板分析
  • 私人公司
    • 主要新兴企业名单
  • 公司简介
    • QIAGEN
    • Illumina, Inc.
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • BIOMERIEUX
    • Agilent Technologies, Inc.
    • F. Hoffmann-La Roche Ltd.
    • PerkinElmer, Inc.
    • Applied Micro Arrays
Product Code: GVR-4-68040-038-5

DNA Microarray Market Growth & Trends:

The global DNA microarray market size is expected to reach USD 3.53 billion by 2030, registering CAGR of 8.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The DNA microarray market is anticipated to witness exponential growth opportunities owing to the technological advancements and rising R&D investments by the leading participants. In addition, the increasing adoption of DNA microarray technologies in various applications such as genetic disease diagnosis, cancer research, and personalized medicine are the leading factors propelling the global market.

Rapid and accurate disease diagnosis is very crucial for the appropriate treatment of the patients. The recent advances in molecular-level interaction & detection technologies are upgrading clinical diagnostics services by offering novel solutions for diagnosis. Likewi se, the recent advancements in diagnostic DNA microarrays have opened new avenues for the market stakeholders. The DNA microarray technique has applications in genotyping, disease diagnosis, detecting abnormalities, and screening nucleotide polymorphisms.

Moreover, the global DNA microarray market is anticipated to witness exponential growth opportunities owing to the increased research funding, rising healthcare costs, technological advancements, and increased demand for the precision and tailored therapeutic solutions. For instance, according to Med City INVEST Precision Medicine, consumers are increasingly aware of the specific therapies, including precision therapy for treating chronic diseases.

In addition, increased investments by the leading players in the production of effective and advanced diagnostic tools and various strategic initiatives undertaken by the market participants are likely to create new avenues for expansion. For instance, in September 2022, Illumina, Inc. announced the launch of the NovaSeq X Series, a next-generation technology product that can produce more than 20,000 genomes per year. In addition, in September 2021, SCHOTT MINIFAB acquired an Arizona-based microarray solutions company. This acquisition is expected to help the company to strengthen its bioscience capabilities in the U.S.

DNA Microarray Market Report Highlights:

  • The oligonucleotide DNA microarrays segment held the largest share owing to its cost-effectivity and higher capability to monitor the expression of every gene in the genome
  • The complementary DNA microarrays segment is anticipated to register the fastest growth rate because of its wide range of applications in polymorphism screening, genomic DNA clones mapping, and gene discoveries
  • The gene expression analysis segment accounted for the largest market in 2024 due to the adopting gene expression in different applications such as clinical diagnostics, drug discovery, microbiology, and other end-use applications
  • Based on end user, the academic & research institute segment dominated the market in 2024, whereas the diagnostic centers segment is anticipated to be the fastest-growing during the forecast period
  • Asia Pacific is expected to exhibit the fastest growth during the forecast period due to the surge in genomic research funding and increasing awareness about the genetic testing in the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 DNA Microarray Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
      • 3.2.1.1 Increasing adoption of DNA microarray for various applications
      • 3.2.1.2 Increasing prevalence of genetic disorders and cancers
      • 3.2.1.3 Growing research activities
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 High cost involved in the sequencing
      • 3.2.2.2 Availability of cost effetive alternative
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 DNA Microarray: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework

Chapter 4 DNA Microarray Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global DNA Microarray Market, by Type, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Complementary DNA microarrays
      • 4.5.1.1 Complementary DNA microarraysmarket estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.2 Oligonucleotide DNA microarrays
      • 4.5.2.1 Oligonucleotide DNA microarraysmarket estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 DNA Microarray Market Segment Analysis, By Application 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Application Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global DNA Microarray Market, by Application, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Gene expression analysis
      • 5.5.1.1 Gene expression analysis market estimates and forecast, 2018 - 2030, (USD Million)
    • 5.5.2 Genotyping
      • 5.5.2.1 Genotyping market estimates and forecast, 2018 - 2030, (USD Million)
    • 5.5.3 Others
      • 5.5.5.1 Others estimates and forecast, 2018 - 2030, (USD Million)

Chapter 6 DNA Microarray Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 End Use Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global DNA Microarray Market, by End Use, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Pharmaceutical and biotechnology companies
      • 6.5.1.1 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Diagnostic centers
      • 6.5.2.1 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Hospitals and clinics
      • 6.5.3.1 Hospitals and clinics market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Academic and research institute
      • 6.5.3.1 Academic and research institute market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Others
      • 6.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 DNA Microarray Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 SWOT Analysis
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 Middle East & Africa
  • 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
    • 7.6.1 North America
      • 7.6.1.1 North America DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.1.2 U.S.
        • 7.6.1.2.1 Key Country Dynamics
        • 7.6.1.2.2 Competitive Scenario
        • 7.6.1.2.3 Regulatory Framework
        • 7.6.1.2.4 Reimbursement Scenario
        • 7.6.1.2.5 U.S. DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.1.3 Canada
        • 7.6.1.3.1 Key Country Dynamics
        • 7.6.1.3.2 Competitive Scenario
        • 7.6.1.3.3 Regulatory Framework
        • 7.6.1.3.4 Reimbursement Scenario
        • 7.6.1.3.5 Canada DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.1.4 Mexico
        • 7.6.1.4.1 Key Country Dynamics
        • 7.6.1.4.2 Competitive Scenario
        • 7.6.1.4.3 Regulatory Framework
        • 7.6.1.4.4 Reimbursement Scenario
        • 7.6.1.4.5 Mexico DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2 Europe
      • 7.6.2.1 Europe DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.2 UK
        • 7.6.2.2.1 Key Country Dynamics
        • 7.6.2.2.2 Competitive Scenario
        • 7.6.2.2.3 Regulatory Framework
        • 7.6.2.2.4 Reimbursement Scenario
        • 7.6.2.2.5 UK DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.3 Germany
        • 7.6.2.3.1 Key Country Dynamics
        • 7.6.2.3.2 Competitive Scenario
        • 7.6.2.3.3 Regulatory Framework
        • 7.6.2.23.4 Reimbursement Scenario
        • 7.6.2.3.5 Germany DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.4 Spain
        • 7.6.2.4.1 Key Country Dynamics
        • 7.6.2.4.2 Competitive Scenario
        • 7.6.2.4.3 Regulatory Framework
        • 7.6.2.4.4 Reimbursement Scenario
        • 7.6.2.4.5 Spain DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.5 France
        • 7.6.2.5.1 Key Country Dynamics
        • 7.6.2.5.2 Competitive Scenario
        • 7.6.2.5.3 Regulatory Framework
        • 7.6.2.5.4 Reimbursement Scenario
        • 7.6.2.5.5 France DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.6 Italy
        • 7.6.2.6.1 Key Country Dynamics
        • 7.6.2.6.2 Competitive Scenario
        • 7.6.2.6.3 Regulatory Framework
        • 7.6.2.6.4 Reimbursement Scenario
        • 7.6.2.6.5 Italy DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.7 Denmark
        • 7.6.2.7.1 Key Country Dynamics
        • 7.6.2.7.2 Competitive Scenario
        • 7.6.2.7.3 Regulatory Framework
        • 7.6.2.7.4 Reimbursement Scenario
        • 7.6.2.7.5 Denmark DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.8 Sweden
        • 7.6.2.8.1 Key Country Dynamics
        • 7.6.2.8.2 Competitive Scenario
        • 7.6.2.8.3 Regulatory Framework
        • 7.6.2.8.4 Reimbursement Scenario
        • 7.6.2.8.5 Sweden DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.2.9 Norway
        • 7.6.2.9.1 Key Country Dynamics
        • 7.6.2.9.2 Competitive Scenario
        • 7.6.2.9.3 Regulatory Framework
        • 7.6.2.9.4 Reimbursement Scenario
        • 7.6.2.9.5 Norway DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3 Asia Pacific
      • 7.6.3.1 Asia Pacific DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.3.2 Japan
        • 7.6.3.2.1 Key Country Dynamics
        • 7.6.3.2.2 Competitive Scenario
        • 7.6.3.2.3 Regulatory Framework
        • 7.6.3.2.4 Reimbursement Scenario
        • 7.6.3.2.5 Japan DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.3.3 China
        • 7.6.3.3.1 Key Country Dynamics
        • 7.6.3.3.2 Competitive Scenario
        • 7.6.3.3.3 Regulatory Framework
        • 7.6.3.3.4 Reimbursement Scenario
        • 7.6.3.3.5 China DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.3.4 India
        • 7.6.3.4.1 Key Country Dynamics
        • 7.6.3.4.2 Competitive Scenario
        • 7.6.3.4.3 Regulatory Framework
        • 7.6.3.4.4 Reimbursement Scenario
        • 7.6.3.4.5 India DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.3.5 South Korea
        • 7.6.3.5.1 Key Country Dynamics
        • 7.6.3.5.2 Competitive Scenario
        • 7.6.3.5.3 Regulatory Framework
        • 7.6.3.5.4 Reimbursement Scenario
        • 7.6.3.5.5 South Korea DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.3.6 Australia
        • 7.6.3.6.1 Key Country Dynamics
        • 7.6.3.6.2 Competitive Scenario
        • 7.6.3.6.3 Regulatory Framework
        • 7.6.3.6.4 Reimbursement Scenario
        • 7.6.3.6.5 Australia DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.3.7 Thailand
        • 7.6.3.7.1 Key Country Dynamics
        • 7.6.3.7.2 Competitive Scenario
        • 7.6.3.7.3 Regulatory Framework
        • 7.6.3.7.4 Reimbursement Scenario
        • 7.6.3.7.5 Thailand DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4 Latin America
      • 7.6.4.1 Latin America DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.4.2 Brazil
        • 7.6.4.2.1 Key Country Dynamics
        • 7.6.4.2.2 Competitive Scenario
        • 7.6.4.2.3 Regulatory Framework
        • 7.6.4.2.4 Reimbursement Scenario
        • 7.6.4.2.5 Brazil DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.4.4 Argentina
        • 7.6.4.4.1 Key Country Dynamics
        • 7.6.4.4.2 Competitive Scenario
        • 7.6.4.4.3 Regulatory Framework
        • 7.6.4.4.4 Reimbursement Scenario
        • 7.6.4.4.5 Argentina DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5 MEA
      • 7.6.5.1 MEA DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.5.2 South Africa
        • 7.6.5.2.1 Key Country Dynamics
        • 7.6.5.2.2 Competitive Scenario
        • 7.6.5.2.3 Regulatory Framework
        • 7.6.5.2.4 Reimbursement Scenario
        • 7.6.5.2.5 South Africa DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.5.3 Saudi Arabia
        • 7.6.5.3.1 Key Country Dynamics
        • 7.6.5.3.2 Competitive Scenario
        • 7.6.5.3.3 Regulatory Framework
        • 7.6.5.3.4 Reimbursement Scenario
        • 7.6.5.3.5 Saudi Arabia DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.5.4 UAE
        • 7.6.5.4.1 Key Country Dynamics
        • 7.6.5.4.2 Competitive Scenario
        • 7.6.5.4.3 Regulatory Framework
        • 7.6.5.4.4 Reimbursement Scenario
        • 7.6.5.4.5 UAE DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.5.5 Kuwait
        • 7.6.5.5.1 Key Country Dynamics
        • 7.6.5.5.2 Competitive Scenario
        • 7.6.5.5.3 Regulatory Framework
        • 7.6.5.5.4 Reimbursement Scenario
        • 7.6.5.5.5 Kuwait DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 DNA Microarray Market - Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 8.1.1 Ansoff matrix
    • 8.1.2 Heat map analysis
    • 8.1.3 Major Deals and Strategic Alliances Analysis
      • 8.1.3.1 Joint Ventures
      • 8.1.3.2 Licensing Agreements
      • 8.1.3.3 Product Launches
      • 8.1.3.1 Conferences and Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
  • 8.4 Public Companies
    • 8.4.1 Competitive Dashboard Analysis
      • 8.4.1.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List of key emerging companies
  • 8.6 Company Profiles
    • 8.6.1 QIAGEN
      • 8.6.1.1 Company overview
      • 8.6.1.2 Financial performance
      • 8.6.1.3 Product benchmarking
      • 8.6.1.4 Strategic Initiatives
    • 8.6.2 Illumina, Inc.
      • 8.6.2.1 Company overview
      • 8.6.2.2 Financial performance
      • 8.6.2.3 Product benchmarking
      • 8.6.2.4 Strategic Initiatives
    • 8.6.3 Merck KGaA
      • 8.6.3.1 Company overview
      • 8.6.3.2 Financial performance
      • 8.6.3.3 Product benchmarking
      • 8.6.3.4 Strategic Initiatives
    • 8.6.4 Thermo Fisher Scientific, Inc.
      • 8.6.4.1 Company overview
      • 8.6.4.2 Financial performance
      • 8.6.4.3 Product benchmarking
      • 8.6.4.4 Strategic Initiatives
    • 8.6.5 BIOMERIEUX
      • 8.6.5.1 Company overview
      • 8.6.5.2 Financial performance
      • 8.6.5.3 Product benchmarking
      • 8.6.5.4 Strategic Initiatives
    • 8.6.6 Agilent Technologies, Inc.
      • 8.6.6.1 Company overview
      • 8.6.6.2 Financial performance
      • 8.6.6.3 Product benchmarking
      • 8.6.6.4 Strategic Initiatives
    • 8.6.7 F. Hoffmann-La Roche Ltd.
      • 8.6.7.1 Company overview
      • 8.6.7.2 Financial performance
      • 8.6.7.3 Product benchmarking
      • 8.6.7.4 Strategic initiatives
    • 8.6.8 PerkinElmer, Inc.
      • 8.6.8.1 Company overview
      • 8.6.8.2 Financial performance
      • 8.6.8.3 Product benchmarking
      • 8.6.8.4 Strategic initiatives
    • 8.6.9 Applied Micro Arrays
      • 8.6.9.1 Company overview
      • 8.6.9.2 Financial performance
      • 8.6.9.3 Product benchmarking
      • 8.6.9.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global DNA Microarray Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Mexico DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Mexico DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 UK DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 UK DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 UK DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 France DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 France DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Spain DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Spain DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Italy DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Denmark DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Norway DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Norway DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Sweden DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Sweden DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53 Japan DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Japan DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Japan DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 China DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 China DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 China DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 India DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 India DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 South Korea DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 South Korea DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Australia DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Australia DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Australia DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Thailand DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Thailand DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 Latin America DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Brazil DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Brazil DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East and Africa DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 DNA microarray market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 DNA Microarray market: Type movement analysis
  • Fig. 17 DNA Microarray market: Type segment dashboard
  • Fig. 18 DNA Microarray market Type outlook: Key takeaways
  • Fig. 19 Complementary DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Oligonucleotide DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 DNA Microarray market: Application movement analysis
  • Fig. 22 DNA Microarray market: Application segment dashboard
  • Fig. 23 DNA Microarray market Application outlook: Key takeaways
  • Fig. 24 Gene expression analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Genotyping market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 DNA Microarray market: End Use movement analysis
  • Fig. 28 DNA Microarray market: End Use segment dashboard
  • Fig. 29 DNA Microarray market End Use outlook: Key takeaways
  • Fig. 30 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Hospitals and clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Academic and research institute market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Regional outlook, 2024 & 2030
  • Fig. 36 Regional market dashboard
  • Fig. 37 Regional market place: Key takeaways
  • Fig. 38 North America, SWOT
  • Fig. 39 Europe, SWOT
  • Fig. 40 Asia Pacific, SWOT
  • Fig. 41 Latin America, SWOT
  • Fig. 42 Middle East and Africa, SWOT
  • Fig. 43 North America
  • Fig. 44 North America DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S.
  • Fig. 46 U.S. DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada
  • Fig. 48 Canada DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 51 UK.
  • Fig. 52 UK DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 55 Spain
  • Fig. 56 Spain DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 57 France
  • Fig. 58 France DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 59 Italy
  • Fig. 60 Italy DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark
  • Fig. 62 Denmark DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 63 Norway
  • Fig. 64 Norway DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden
  • Fig. 66 Sweden DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia Pacific DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 69 Japan
  • Fig. 70 Japan DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 71 China
  • Fig. 72 China DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 74 India DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 75 South Korea
  • Fig. 76 South Korea DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 77 Australia
  • Fig. 78 Australia DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 79 Thailand
  • Fig. 80 Thailand DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico
  • Fig. 86 Mexico DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina
  • Fig. 88 Argentina DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa
  • Fig. 90 MEA DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE
  • Fig. 96 UAE DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait
  • Fig. 98 Kuwait DNA microarray market, 2018 - 2030 (USD Million)
  • Fig. 99 Strategy Mapping